Inventor

DEMUTH HANS-ULRICH

DE66 patents

⚠️ This page may combine multiple inventors who share the name “DEMUTH HANS-ULRICH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DEMUTH HANS-ULRICH

PROBIODRUG AG

Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease

Inhibitors of glutaminyl cyclase

Inhibitors of glutaminyl cyclase

Effectors of dipeptidyl peptidase IV

Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases

Method for the improvement of islet signaling in diabetes mellitus and for its prevention

Use of effectors of glutaminyl and glutamate cyclases

Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents

Effectors of dipeptidyl peptidase IV for topical use

Inhibitors of dipeptidyl peptidase I

Prodrugs of DP IV-inhibitors

Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders

Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents

Inhibitors

Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase IV inhibitors

Dipeptidyl peptidase IV inhibitors for the treatment of anxiety

Inhibitors of prolyl endopeptidase

Inhibitors of glutaminyl cyclase

Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis

Inhibitors

Method for the production of thiazolidin

Radiolabelled glutaminyl cyclase (QC) inhibitors and uses of same

Inhibitors

Inhibitors of glutaminyl cyclase

Effectors of dipeptidyl peptidase IV for topical use

Inhibitors of dipeptidyl peptidase I

Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)

SCHILLING STEPHAN

Method of screening for inhibitors of glutaminyl cyclase activity

Transgenic mouse models of Aβ overexpression

Method of treating inflammation with glutaminyl cyclase inhibitors

Mouse carrying a knock-out mutation of the Qpct-gene

Use of effectors of glutaminyl and glutamate cyclases

HEISER ULRICH

Inhibitors

Inhibitors

Radiolabeled glutaminyl cyclase (QC) inhibitors and uses of same

Inhibitors of glutaminyl cyclase

Inhibitors

DEMUTH HANS-ULRICH

Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides

Glutaminyl based DPIV inhibitors

Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions

Use of inhibtors of glutaminyl cyclases for treatment and prevention of disease

PROSIDION LTD

Compounds of unstable DP IV-inhibitors

Methods for improving islet signaling in diabetes mellitus and for its prevention

Prodrugs of DP IV-inhibitors

Glutaminyl based DPIV inhibitors

PROBIODRUG

Raising blood sugar level in hypoglycemic mammals by administering inhibitors of dipeptidyl peptidase IV

Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals

FRAUNHOFER GES FORSCHUNG

Inhibitors of meprin α and β

HOFFMANN TORSTEN

Method for prophylactic treatment of alzheimer&#39;s disease using inhibitors of glutaminyl cyclase and glutamate cyclases

VIVORYON THERAPEUTICS N V

Inhibitors of meprin α and β

Method for prophylactic treatment of alzheimer's disease using inhibitors of glutaminyl cyclase and glutamate cyclases